Literature DB >> 22403086

Myocardial infarction and generalised anxiety disorder: 10-year follow-up.

Annelieke M Roest1, Marij Zuidersma, Peter de Jonge.   

Abstract

BACKGROUND: Few studies have addressed the relationship between generalised anxiety disorder and cardiovascular prognosis using a diagnostic interview. AIMS: To assess the association between generalised anxiety disorder and adverse outcomes in patients with myocardial infarction.
METHOD: Patients with acute myocardial infarction (n = 438) were recruited between 1997 and 2000 and were followed up until 2007. Current generalised anxiety disorder and post-myocardial infarction depression were assessed with the Composite International Diagnostic Interview. The end-point consisted of all-cause mortality and cardiovascular-related readmissions.
RESULTS: During the follow-up period, 198 patients had an adverse event. Generalised anxiety disorder was associated with an increased rate of adverse events after adjustment for age and gender (hazard ratio: 1.94; 95% confidence interval: 1.14-3.30; P = 0.01). Additional adjustment for measures of cardiac disease severity and depression did not change the results.
CONCLUSIONS: Generalised anxiety disorder was associated with an almost twofold increased risk of adverse outcomes independent demographic and clinical variables and depression.

Entities:  

Mesh:

Year:  2012        PMID: 22403086     DOI: 10.1192/bjp.bp.111.103549

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  30 in total

Review 1.  Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: A systematic review.

Authors:  Christina M DuBois; Oriana Vesga Lopez; Eleanor E Beale; Brian C Healy; Julia K Boehm; Jeff C Huffman
Journal:  Int J Cardiol       Date:  2015-05-21       Impact factor: 4.164

Review 2.  Selected psychological comorbidities in coronary heart disease: Challenges and grand opportunities.

Authors:  Karina W Davidson; Carmela Alcántara; Gregory E Miller
Journal:  Am Psychol       Date:  2018-11

Review 3.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

4.  The effects of optimism and gratitude on adherence, functioning and mental health following an acute coronary syndrome.

Authors:  Rachel A Millstein; Christopher M Celano; Eleanor E Beale; Scott R Beach; Laura Suarez; Arianna M Belcher; James L Januzzi; Jeff C Huffman
Journal:  Gen Hosp Psychiatry       Date:  2016-08-30       Impact factor: 3.238

Review 5.  Anxiety and Cardiovascular Disease Risk: a Review.

Authors:  Phillip J Tully; Nathan J Harrison; Peter Cheung; Suzanne Cosh
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

6.  Risk of Rehospitalization can be Reduced.

Authors:  Arnim Quante
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

Review 7.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

Review 8.  Anxiety disorders and all-cause mortality: systematic review and meta-analysis.

Authors:  Beyon Miloyan; Adam Bulley; Karen Bandeen-Roche; William W Eaton; Daniela C Gonçalves-Bradley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-09-14       Impact factor: 4.328

Review 9.  Anxiety Disorders and Cardiovascular Disease.

Authors:  Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

10.  Associations of physical activity with anxiety symptoms and status: results from The Irish longitudinal study on ageing.

Authors:  C P McDowell; B R Gordon; K L Andrews; C MacDonncha; M P Herring
Journal:  Epidemiol Psychiatr Sci       Date:  2018-01-31       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.